62243-70-3 Usage
Uses
Used in Pharmaceutical Industry:
2-(4-Fluorophenyl)morpholine HCl is utilized as a pharmaceutical intermediate for the synthesis of various drugs. Its unique chemical structure allows it to serve as a building block in the creation of new medicinal compounds, contributing to the development of novel treatments.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 2-(4-Fluorophenyl)morpholine HCl is employed as a research compound. Its properties and interactions with biological systems are studied to understand its potential therapeutic effects and to explore its use in the design of new pharmaceuticals.
Used in Antipsychotic Drug Development:
2-(4-Fluorophenyl)morpholine HCl is considered for its potential as an antipsychotic agent. Its application in this area is driven by the need for new and effective treatments for psychiatric disorders, with the compound's unique structure offering a promising avenue for the development of innovative medications.
Check Digit Verification of cas no
The CAS Registry Mumber 62243-70-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,2,2,4 and 3 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 62243-70:
(7*6)+(6*2)+(5*2)+(4*4)+(3*3)+(2*7)+(1*0)=103
103 % 10 = 3
So 62243-70-3 is a valid CAS Registry Number.
62243-70-3Relevant academic research and scientific papers
DOPAMINE D3 RECEPTOR ANTAGONISTS HAVING A MORPHOLINE MOIETY
-
, (2018/11/21)
The disclosure provides compounds of formula (I) or pharmaceutically acceptable salts thereof: The disclosure also provides processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them, and their use
Novel morpholine scaffolds as selective dopamine (DA) D3 receptor antagonists
Micheli, Fabrizio,Cremonesi, Susanna,Semeraro, Teresa,Tarsi, Luca,Tomelleri, Silvia,Cavanni, Paolo,Oliosi, Beatrice,Perdon, Elisabetta,Sava, Anna,Zonzini, Laura,Feriani, Aldo,Braggio, Simone,Heidbreder, Christian
, p. 1329 - 1332 (2016/02/23)
A new series of morpholine derivatives has been identified as selective DA D3 receptor antagonists; their in vitro profile and pharmacokinetic data are provided.
